This is the renewal application for a multidisciplinary training program in Pulmonary and Critical Care Medicine (PCCM) at the David Geffen School of Medicine (DGSOM) at UCLA. The training program will continue to provide training in basic science and clinical research relevant to the study of PCCM-related diseases. The program proposes to continue to support a total of six postdoctoral trainees (M.D.s, Ph.D.s and M.D./Ph.D.s) for a two year experience in a highly structured environment under the close supervision of faculty mentors. The trainees will take advantage of experienced faculty mentors whose research encompasses themes of 1) Infection/Inflammation/Transplantation (Belperio, Cheng, Deng, Horwitz, and Modlin), 2) Lung Carcinogenesis (Dubinett, Gomperts, and Sharma), 3) Iron Metabolism (Ganz, Nemeth) and 4) Health Services Research and Prevention (London, Needleman, and Wenger). The program will continue to utilize faculty mentors from several Departments in the DGSOM, and the School of Public Health at UCLA. The faculty mentors have extensive research experience in diverse yet overlapping areas of molecular and cellular biology, biostatistics, epidemiology, clinical study design or medical ethics. The faculty mentors have previously trained postdoctoral trainees, who have subsequently gone on to independent and productive careers in academia or industry. The environment at UCLA together with the faculty mentors will continue to offer an outstanding experience for trainees in research disciplines relevant to PCCM-related diseases. The program will continue to provide a structured curriculum that contains appropriate course work, exposure to relevant lecture series and an intensive basic science or clinical research experience. The training program has been highly successful in developing new investigators with the vast majority of trainees continuing in research careers in academia or industry.

Public Health Relevance

to Public Health The UCLA Pulmonary and Critical Care Medicine Training Program (PCCMTP) trains the next generation of academic and industry leaders in basic, translational and clinical research in pulmonary and critical care medicine (PCCM)-related diseases. Leveraging an exceptionally strong environment in PCCM investigation, the program trainees benefit from the unique and rich resources of a major academic center recognized internationally for its pioneering research in clinically relevant areas. The majority of trainees who have graduated from the PCCMTP continue to fulfill its stated mission by advancing to positions of leadership in academia or industry, and continuing to uncover basic principles in PCCM-related diseases, therefore this research will help to develop the next-generation of therapies based in PCCM research for the betterment of patients.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Internal Medicine/Medicine
Schools of Medicine
Los Angeles
United States
Zip Code
Kim, Airie; Rivera, Seth; Shprung, Dana et al. (2014) Mouse models of anemia of cancer. PLoS One 9:e93283
Liclican, Elvira L; Walser, Tonya C; Hazra, Saswati et al. (2014) Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. Cancer Prev Res (Phila) 7:845-55
Kachroo, Puja; Lee, Mi-Heon; Zhang, Ling et al. (2013) IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res 32:97
Yanagawa, Jane; Walser, Tonya C; Zhu, Li X et al. (2009) Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res 15:6820-9
Dalwadi, Harnisha; Krysan, Kostyantyn; Heuze-Vourc'h, Nathalie et al. (2005) Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 11:7674-82